MRM — MEDIROM Healthcare Technologies Balance Sheet
0.000.00%
- $3.74m
- $13.83m
- ¥7bn
Annual balance sheet for MEDIROM Healthcare Technologies, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 514 | 1,440 | 371 | 605 | 106 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 774 | 560 | 855 | 1,325 | 1,228 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,379 | 2,087 | 1,382 | 2,363 | 1,759 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,999 | 1,815 | 2,249 | 2,380 | 2,541 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,757 | 5,713 | 5,753 | 6,747 | 6,849 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,263 | 2,653 | 3,196 | 3,642 | 3,561 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,157 | 5,222 | 5,961 | 6,807 | 6,638 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 600 | 491 | -208 | -59.4 | 211 |
Total Liabilities & Shareholders' Equity | 4,757 | 5,713 | 5,753 | 6,747 | 6,849 |
Total Common Shares Outstanding |